|
Global Biotech Hub
1. Melbourne is Australia’s biotechnology centre with the largest concentration of listed healthcare and biotech companies - over 50% of all ASX healthcare and biotech companies are headquartered in Melbourne. (Source: http://www.biomelbourne.org)
2. Melbourne has the highest concentration of medical research facilities of any Australian City: over 60% of Australia’s public and private research capability. (Source: http://www.biomelbourne.org)
3. The city has the largest amount of venture capital funds including Australia’s largest biotechnology. VC fund GBS Ventures’ 4th fund of A$150million. (Source: http://www.biomelbourne.org)
4. Melbourne has the country’s largest Public Biotechnology company: CSL Ltd with market capitalisation of A$16.4 bill as at 30 June 07. (Source: http://www.biomelbourne.org)
5. Melbourne is home to the Committee for Melbourne™-initiated Biotechnology business network, the BioMelbourne Network, which has over 160 member organisations. (Source: http://www.biomelbourne.org)
6. Victorian research institutes, universities and hospitals consistently win more than 40% of funding allocated by the National Health and Medical Research Council. Victoria has a unique group of medical research institutes, such as the Walter and Eliza Hall Institute, the Baker Institute, and Howard Florey. (Source: DIIRD)
8. With 629 designs registered in 2004, Victoria accounted for 36% of Australian Design registrations. It was ahead of NSW with 576 designs or 33% of the Australian registrations. (Source: DIIRD)  |